Point72 Asset Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
93,721
+91,531
| +4,179% | +$333K | ﹤0.01% | 1136 |
|
|
2025
Q1 | $4.21K | Buy |
+2,190
| New | +$4.21K | ﹤0.01% | 1215 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1029 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1044 |
|
|
2020
Q3 | – | Sell |
-734,028
| Closed | -$9.97M | – | 846 |
|
|
2020
Q2 | $9.97M | Sell |
734,028
-1,240,292
| -63% | -$16.8M | 0.07% | 325 |
|
|
2020
Q1 | $15M | Sell |
1,974,320
-383,780
| -16% | -$2.91M | 0.12% | 237 |
|
|
2019
Q4 | $14.9M | Buy |
2,358,100
+585,800
| +33% | +$3.7M | 0.08% | 291 |
|
|
2019
Q3 | $6.95M | Buy |
1,772,300
+148,900
| +9% | +$584K | 0.04% | 378 |
|
|
2019
Q2 | $7.86M | Buy |
+1,623,400
| New | +$7.86M | 0.04% | 368 |
|
|
2019
Q1 | – | Sell |
-504,373
| Closed | -$2.79M | – | 894 |
|
|
2018
Q4 | $2.79M | Buy |
504,373
+206,161
| +69% | +$1.14M | 0.01% | 583 |
|
|
2018
Q3 | $2.63M | Buy |
+298,212
| New | +$2.63M | 0.01% | 585 |
|
|
2018
Q2 | – | Sell |
-194,150
| Closed | -$1.85M | – | 790 |
|
|
2018
Q1 | $1.85M | Buy |
+194,150
| New | +$1.85M | 0.01% | 607 |
|
|
2016
Q2 | – | Sell |
-100
| Closed | -$1K | – | 639 |
|
|
2016
Q1 | $1K | Sell |
100
-41,900
| -100% | -$419K | ﹤0.01% | 634 |
|
|
2015
Q4 | $543K | Buy |
+42,000
| New | +$543K | ﹤0.01% | 582 |
|